Israeli strikes in Gaza as some aid restrictions eased
Israel announced on Sunday that the military would pause operations in Gaza City, Deir al-Balah and Muwasi for 10 hours a day until further notice to allow for the improved flow of aid to Palestinians in Gaza, where concern over hunger has grown, and designate secure routes for aid delivery.
Israel said it would continue military operations alongside the new humanitarian measures.
The Israeli military had no immediate comment about the latest strikes, which occurred outside the time frame for the pause Israel declared would be held between 10am and 8pm.
Aid agencies have welcomed the new aid measures, which also included allowing airdrops into Gaza, but said they were not enough to counter the rising hunger in the Palestinian territory.
Images of emaciated children have sparked outrage around the world, including from Israel's close allies.
US President Donald Trump on Sunday called the images of emaciated and malnourished children in Gaza "terrible".
Israel has restricted aid to varying degrees throughout the war.
In March, it cut off the entry of all goods, including fuel, food and medicine to pressure Hamas to free hostages.
Israel partially lifted those restrictions in May but also pushed ahead on a new US-backed aid delivery system that has been racked by chaos and violence.
Traditional aid providers also have encountered a similar breakdown in law and order surrounding their aid deliveries.
Most of Gaza's population now relies on aid. Accessing food has become a challenge that some Palestinians have risked their lives for.
The Awda hospital in central Gaza said it received the bodies of seven Palestinians who it said were killed on Monday by Israeli fire close to an aid distribution site run by the US- and Israeli-backed Gaza Humanitarian Foundation.
The hospital said 20 others were wounded close to the site.
Elsewhere, a woman who was seven months pregnant was killed along with 11 others after their house was struck in the Muwasi area, west of the southern city of Khan Younis.
The woman's fetus survived after a complex surgery, according to the Palestinian Red Crescent.
One strike hit a two-storey house in the western Japanese neighbourhood of Khan Younis, killing at least 11 people, more than half of them women and children, said the Nasser Hospital, which received the casualties.
The Israeli military and GHF did not immediately respond to a request for comment on those strikes.
In its October 7, 2023, attack, Hamas killed 1200 people and took 251 hostages.
It still holds 50, more than half Israel believes to be dead.
Israel's retaliatory offensive has killed more than 59,800 Palestinians, according to Gaza's health ministry.
Its count does not distinguish between militants and civilians, but the ministry says over half of the dead are women and children.
The ministry operates under the Hamas government.
The UN and other international organisations see it as the most reliable source of data on casualties.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
14 hours ago
- News.com.au
Lunch Wrap: ASX slips heavily, Novonix scraps graphite spin-out
Banks, tech and health take a dive ResMed surged after smashing earnings The ASX 200 was down by 0.75% at lunch time in the eastern states, with investors firmly in risk-off mode. Only miners and utilities put up a fight. Everywhere else, it was a mess. Health stocks were out of breath, tech looked like it had skipped leg day, and the big banks all sagged under the weight of global tariff fears. It's the kind of day where even the good names get dragged through the mud. Commonwealth Bank (ASX:CBA), National Australia Bank (ASX:NAB), WiseTech Global (ASX:WTC) and Xero (ASX:XRO) all retreated. This all followed another tariff tantrum from Donald Trump. Canada just got hit with a jump from 25% to 35%, and new levies were slapped on Thailand, Cambodia, Taiwan and Switzerland. Australia, somehow, managed to dodge the full swing, for now. But with tariffs pushing up import prices, bets on US rate cuts just got punted out to October. In the large caps space, conglomerate Washington H Soul Pattinson (ASX:SOL) nudged lower despite lifting its dividend again - its 27th annual increase, if you don't mind. Downer EDI (ASX:DOW) bagged a fresh $220 million defence deal, and ResMed (ASX:RMD) surged after smashing earnings expectations with a 37% jump in profit. ResMed reckons it will keep growing even with Ozempic and its weight loss-pill mates nipping at the edges of the sleep apnoea market. Gold producer Bellevue Gold (ASX:BGL) climbed after setting bullish production guidance of up to 150,000 ounces in FY26. Meanwhile, Novonix (ASX:NVX) and Lithium Energy (ASX:LEL) have pulled the plug on the Axon Graphite IPO and the Mt Dromedary deal, citing weak market conditions. Novonix is now reviewing next steps for Mt Dromedary, and its directors have resigned from the Axon board. Shares were flat. ASX SMALL CAP WINNERS Here are the best performing ASX small cap stocks for August 1 : Security Description Last % Volume MktCap CYQ Cycliq Group Ltd 0.005 150% 7,878,960 $921,033 DMG Dragon Mountain Gold 0.013 117% 725,258 $2,368,030 1AE Aurora Energy Metals 0.081 62% 1,792,535 $8,953,187 LNR Lanthanein Resources 0.002 50% 17,675,218 $3,734,001 RLG Roolife Group Ltd 0.004 33% 70,872 $4,778,344 AON Apollo Minerals Ltd 0.009 29% 150,000 $6,499,198 4DX 4Dmedical Limited 0.300 25% 9,364,191 $111,729,714 CTN Catalina Resources 0.005 25% 200,000 $9,704,076 GSM Golden State Mining 0.010 25% 252,061 $2,234,965 MEL Metgasco Ltd 0.003 25% 125,337 $3,674,173 PIL Peppermint Inv Ltd 0.003 25% 200,090 $4,602,180 QXR Qx Resources Limited 0.005 25% 5,200,000 $5,241,315 VRC Volt Resources Ltd 0.005 25% 4,040,000 $18,739,398 LKY Locksleyresources 0.130 24% 26,437,175 $19,250,000 8CO 8Common Limited 0.026 24% 1,176,072 $4,705,993 SPG Spc Global Holdings 0.405 23% 75,363 $63,684,021 IR1 Irismetals 0.110 22% 522,009 $16,016,344 DTM Dart Mining NL 0.003 20% 6,303,558 $2,995,139 RAN Range International 0.003 20% 1,846,960 $2,348,226 GBE Globe Metals &Mining 0.052 18% 685,582 $30,564,732 EXL Elixinol Wellness 0.020 18% 340,750 $3,913,254 STM Sunstone Metals Ltd 0.020 18% 23,846,808 $104,874,083 CCO The Calmer Co Int 0.004 17% 143,000 $9,034,060 CHM Chimeric Therapeutic 0.004 17% 768,284 $9,747,370 HPC Thehydration 0.015 15% 116,666 $5,600,412 Dragon Mountain Gold (ASX:DMG) surged after revealing that it has repaid its October 2024 convertible loan and interest in full, using funds from a new loan provided by an unrelated major shareholder. The move clears the slate and gives DMG more flexibility for future capital raising, as well as assessing new or existing project opportunities. Aurora Energy Metals (ASX:1AE) says Eagle Energy Metals, which holds an option over its Aurora Uranium Project (AUP) in Oregon, is planning to list on the Nasdaq via a SPAC merger with Spring Valley Acquisition Corp. II. If the deal goes through, Aurora will receive US$16 million in Eagle shares, with more to come via milestones and a 1% royalty on future uranium production. Locksley Resources (ASX:LKY) has locked in a heavily oversubscribed $5.3 million raise at $0.095 a share, with strong backing from institutional investors led by Tribeca Investment Partners. The fresh funds will go into drilling high-grade antimony and rare earths at its Mojave project in California, progressing downstream processing in the US. LKY says the raise is a big vote of confidence in its US critical minerals strategy, with more than a dozen new institutions joining the register. Settlement is expected around August 6, with the raise split across two tranches – one already approved, and one pending shareholder tick. ASX SMALL CAP LOSERS Here are the worst performing ASX small cap stocks for August 1 : Code Name Price % Change Volume Market Cap PAB Patrys Limited 0.002 -25% 74,887 $4,731,620 ROG Red Sky Energy. 0.003 -25% 3,106,371 $21,688,909 SYR Syrah Resources 0.275 -24% 12,731,271 $376,567,220 SPX Spenda Limited 0.006 -20% 32 $34,614,116 1TT Thrive Tribe Tech 0.008 -20% 153,010 $1,015,864 GGE Grand Gulf Energy 0.002 -20% 21,282,858 $7,051,062 KNG Kingsland Minerals 0.105 -19% 127,677 $9,432,918 OKJ Oakajee Corp Ltd 0.048 -17% 349,874 $5,303,870 ALM Alma Metals Ltd 0.005 -17% 1,985,774 $11,104,423 ID8 Identitii Limited 0.005 -17% 890,791 $4,668,081 VEN Vintage Energy 0.005 -17% 2,587,531 $12,521,482 LSR Lodestar Minerals 0.016 -16% 728,056 $7,554,219 AIV Activex Limited 0.011 -15% 383,554 $2,801,534 BDM Burgundy D Mines Ltd 0.028 -15% 1,505,337 $46,903,965 YRL Yandal Resources 0.115 -15% 775,878 $41,746,723 GTR Gti Energy Ltd 0.003 -14% 6,150,000 $13,029,292 PLC Premier1 Lithium Ltd 0.006 -14% 330,372 $2,576,424 USL Unico Silver Limited 0.340 -13% 3,032,364 $170,798,064 OD6 Od6Metalsltd 0.021 -13% 577,267 $3,851,231 TX3 Trinex Minerals Ltd 0.110 -12% 516,223 $5,835,180 BEO Beonic Ltd 0.265 -12% 30,000 $21,258,302 MVP Medical Developments 0.540 -11% 71,639 $68,721,578 IN CASE YOU MISSED IT Pure Hydrogen (ASX:PH2) looks to focus on battery electric and hydrogen fuel cell vehicles along with hydrogen equipment, proposing a name change to Pure One. LAST ORDERS DY6 Metals (ASX:DY6) has welcomed Dr Moses Ndasi as in-country manager for Cameroon, bringing more than 20 years' experience in minerals and mining throughout Africa with him. DY6 has also promoted Troth Saindi to exploration manager for Africa, Geoffrey Banda to project geologist, Africa, and Corné Coetser will transition to senior exploration geologist. HyTerra (ASX:HYT) has drilled the McCoy 1 well at the Nemaha hydrogen and helium project in Kansas to a total depth of 5562 feet, on time, within budget, with no safety incidents. McCoy 1 will be converted to an appraisal well over the coming days with a workover rig to proactively monitor the well and evaluate flow test viability. Arika Resources (ASX:ARI) has tapped geologist Steve Vallance as technical director, leveraging his 35 years' experience in gold and nickel sulphide deposits. He most recently served as chief exploration geologist for Jubilee Mines, where he co-led discoveries that eventually led to a $3.3b acquisition by Xstrata Nickel. Star Minerals (ASX:SMS) has advanced four separate permitting studies to the final draft stage, preparing to submit formal applications for flora and fauna, subterranean fauna, and hydrogeology and hydrology assessments and a geological and geotechnical report. With only a few permits left to obtain, SMS says its mining approval application is nearing completion. At Stockhead, we tell it like it is. While DY6 Metals, HyTerra, Arika Resources and Star Minerals are Stockhead advertisers, they did not sponsor this article.
The Age
17 hours ago
- The Age
Trump takes aim at ‘foreign freeloading nations' over drug prices in new threat to PBS
Washington: US President Donald Trump has blamed 'foreign freeloading nations' for the high drug prices faced by Americans and told pharmaceutical firms to negotiate harder with other countries, in a new threat to programs such as Australia's Pharmaceutical Benefits Scheme. Trump issued letters to the bosses of 17 drug firms on Thursday (Friday AEST) demanding they extend 'most favoured nation' pricing to the US Medicaid scheme, and guarantee such pricing for new drugs. It means other comparable, high-income nations could not be offered cheaper prices than the US. 'Domestic MFN pricing will require you, and all manufacturers, to negotiate harder with foreign freeloading nations,' Trump wrote in the letters. 'US trade policy will endeavour to support this. However, increased revenues abroad must be repatriated to lower drug prices for American patients and taxpayers through an explicit agreement with the United States.' The letters were sent to major drugmakers including Pfizer, Eli Lilly, AstraZeneca and Johnson & Johnson, and published on Trump's social media. They did not mention Australia but referred to putting 'an end to the free ride of American innovation by European and other developed nations'. Under the PBS, Australians can buy life-saving drugs worth thousands of dollars for as little as $31.60 a script after the government negotiates with the drug company to secure a lower price based on buying in bulk. Trump's letter makes explicit instructions to drug firms to 'negotiate harder' and return those extra profits to American patients and taxpayers.
AU Financial Review
19 hours ago
- AU Financial Review
Resmed beats forecasts as annual sleep device sales hit $8bn
Resmed has beaten full-year earnings and revenue forecasts on the back of strong global sales of its devices to treat sleep apnoea, shrugging off the threat of Donald Trump's trade tariffs and flagging a significant improvement in margins this year. California-based Resmed, which was founded in Sydney 35 years ago and is listed on the Nasdaq and the ASX, said net profit rose 37 per cent to $US1.4 billion ($2.2 billion) in the year to June 30, while revenue for the year increased 10 per cent to $US5.1 billion.
